Compounds > topotecan
Page last updated: 2024-08-24

topotecan and aphidicolin

topotecan has been researched along with aphidicolin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaufmann, SH1
Berger, NA; Chatterjee, S; Cheng, MF1
Albig, W; Doenecke, D; Kratzmeier, M; Meinl, A; Schliephacke, T1
Bhalla, K; Blaskovich, MA; Dunne, J; Gasparetto, M; Gentry, T; Haaland, P; Nimmanapalli, R; O'Bryan, E; Rizzieri, D; Sebti, S; Smith, C1

Other Studies

4 other study(ies) available for topotecan and aphidicolin

ArticleYear
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Cancer research, 1991, Feb-15, Volume: 51, Issue:4

    Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured

1991
Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens.
    Oncology research, 1994, Volume: 6, Issue:6

    Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Camptothecin; Carmustine; Cell Cycle; Cell Death; Cell Line; Cisplatin; Cricetinae; Cricetulus; DNA Damage; DNA Repair; DNA, Neoplasm; Doxorubicin; Drug Synergism; Etoposide; Fibroblasts; Hydroxyurea; Lung; Melphalan; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan

1994
The telomeric region is excluded from nucleosomal fragmentation during apoptosis, but the bulk nuclear chromatin is randomly degraded.
    Cell death and differentiation, 2004, Volume: 11, Issue:7

    Topics: Aphidicolin; Apoptosis; Cell Line, Tumor; Cell Nucleus; Chromatin; Enzyme Inhibitors; HL-60 Cells; Humans; Kinetics; Micrococcal Nuclease; Nucleosomes; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Telomere; Topotecan

2004
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.
    Journal of immunological methods, 2004, Volume: 292, Issue:1-2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aphidicolin; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lymphoma; Phenanthrolines; Rituximab; Topotecan

2004